NovoCure Dividend
Dividend criteria checks 0/6
NovoCure no tiene antecedentes de pago de dividendos.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.93 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
NovoCure: Sell The METIS-Inspired Rally
Mar 28Some Shareholders Feeling Restless Over NovoCure Limited's (NASDAQ:NVCR) P/S Ratio
Mar 03NovoCure: Stay Cautious Amid Positive Signs
Jan 19Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?
Nov 16Is NovoCure (NASDAQ:NVCR) Weighed On By Its Debt Load?
Aug 13Is NovoCure (NASDAQ:NVCR) A Risky Investment?
May 15A Look At The Intrinsic Value Of NovoCure Limited (NASDAQ:NVCR)
Apr 24Why NovoCure Limited (NASDAQ:NVCR) Could Be Worth Watching
Feb 10Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?
Jan 16NovoCure: See Past Market Myopia And Buy The Dip
Sep 27Novocure creates new CNS focused franchise to renew growth in brain cancer business
Sep 21Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?
Sep 09NovoCure: Does The Reward Outweigh The Risk? I Believe So
Sep 09NovoCure Q2 2022 Earnings Preview
Jul 27Is NovoCure (NASDAQ:NVCR) Using Too Much Debt?
May 28NovoCure: A Stalwart With More Upsides
May 09NovoCure: Overview Of The GBM Business
Feb 28Health Check: How Prudently Does NovoCure (NASDAQ:NVCR) Use Debt?
Feb 14NovoCure: Time For A Cure
Jan 01NovoCure: Threshold Of Greatness
Nov 30We Think NovoCure (NASDAQ:NVCR) Can Manage Its Debt With Ease
Oct 17NovoCure: TTFields Generating Revenues And Creating Avenues For Further Growth
Sep 13Stability and Growth of Payments
Fetching dividends data
Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de NVCR han sido estables en el pasado.
Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de NVCR han aumentado.
Dividend Yield vs Market
NovoCure Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NVCR) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Medical Equipment) | 1.7% |
Analyst forecast in 3 Years (NVCR) | n/a |
Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de NVCR en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Alto dividendo: No es posible evaluar la rentabilidad por dividendo de NVCR en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.
Earnings Payout to Shareholders
Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de reparto de NVCR para determinar si sus dividendos están cubiertos por los beneficios.
Cash Payout to Shareholders
Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que NVCR no ha comunicado ningún pago.